Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors

We present data on analytical validation of the multigene variant profiling assay (CellDx) to provide actionable indications for selection of targeted and immune checkpoint inhibitor (ICI) therapy in solid tumors. CellDx includes Next Generation Sequencing (NGS) profiling of gene variants in a targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Akolkar, Dadasaheb, Patil, Darshana, Srivastava, Navin, Patil, Revati, Datta, Vineet, Apurwa, Sachin, Yashwante, Nitin, Dhasarathan, Raja, Gosavi, Rahul, John, Jinumary, Khan, Shabishta, Jadhav, Ninad, Mene, Priti, Ahire, Dhanashri, Pawar, Sushant, Bodke, Harshal, Sahoo, Subhraline, Nile, Arun, Saindane, Dinesh, Darokar, Harshal, Devhare, Pradip, Srinivasan, Ajay, Datar, Rajan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870065/
https://www.ncbi.nlm.nih.gov/pubmed/33556149
http://dx.doi.org/10.1371/journal.pone.0246048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870065/
https://www.ncbi.nlm.nih.gov/pubmed/33556149
http://dx.doi.org/10.1371/journal.pone.0246048

Ejemplares similares